Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

26

Apr 2019

Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline

Mateon Therapeutics Inc and Oncotelic Inc announced today that they have completed their previously announced merger The combined company has a focused pipeline of TGF RNA Therapeutics for late stage cancers including gliomas pancreatic cancer and melanoma

26

Apr 2019

Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma

Salix Pharmaceuticals Salix one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Bausch Health Companies Inc announced today that its affiliate has entered into an exclusive licensin...

25

Apr 2019

ADC Therapeutics and Adagene Announce License Agreement

ADC Therapeutics an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates ADCs and Adagene Inc an antibody engineering and discovery company today announced that they have entered into a discovery collaboration and license agreeme...

24

Apr 2019

UroGen Pharma Announces Early Stage Feasibility Agreement with Janssen

UroGen Pharma Ltd a clinicalstage biopharmaceutical company developing treatments to address unmet needs in the field of urooncology today announced that it has entered into an agreement with Janssen Research Development LLC Janssen to conduct an earlystage feasibility evaluation in a therapeutic a...

24

Apr 2019

Lilly and Avidity Biosciences Announce Licensing and Research Collaboration

Eli Lilly and Company and Avidity Biosciences Inc today announced a global licensing and research collaboration focused on the discovery development and commercialization of potential new medicines in immunology and other select indications

press releasesRead more...

26

Apr 2019

Precigen Opens Gene and Cell Therapy Manufacturing Facility in Germantown, Maryland

Precigen Inc a whollyowned subsidiary of Intrexon Corporation and a clinical stage biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients today announced the official opening of its new manufacturing facility

26

Apr 2019

Aurora Bolsters Anandia's Testing Capabilities Through Acquisition of Chemi Pharmaceutical

Aurora Cannabis Inc announced today that the company has signed a binding share purchase agreement whereby Aurora has acquired all of the issued and outstanding common shares of privatelyheld Chemi Pharmaceutical Inc

25

Apr 2019

Garhwal Central University Received First Indian Patent

The HNB Garhwal University A Central Universityhas got the First Indian Patent for years The research work Novel Synergistic Herbal Formulation of WithaniaSomnifera for Antihyperlipidemic and Antiobesity Activity was taken from MPharmacy student of the Department of Pharmaceutical Sciences of Garh...

25

Apr 2019

La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria

La Jolla Pharmaceutical Company a leader in the discovery development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from lifethreatening diseases today announced that the US Food and Drug Administration FDA has granted Breakthrough The...

24

Apr 2019

Velabs Therapeutics to Cooperate with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening

Velabs Therapeutics specializing in the fast generation of functional therapeutic antibodies today announced that it has entered into an agreement with Chiome Bioscience Inc Tokyo to jointly discover modulatory and functional antibodies for one of Chiomes GPCR target genes

EventsRead more...

29 - 01

Apr 2019

29 - 30

Apr 2019

Clinical Research as a Care Option

The Conference Forum
Sheraton Imperial Hotel Raleigh

30 - 01

Apr 2019

6th GCC Healthcare Innovation Congress

Maarefah management
Millennium Dubai Airport Hotel

01 - 02

May 2019

Advertisements

TOP ARTICLES

  • 4

    Are you Ready for EU FMD?

    With the deadline looming for enactment of EU FMD and US DSCSA Vikash Pushpraj Senior Vice President rfxcel ex...

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...
  • Articles

    Nanomedicines management for advance therapy of NeuroAIDS: State of art

    Introduction The Human Immune deficiency Virus HIV infected brain cells through virus or HIV linked oncogenes The major complication of such infection leads to dementia peripheral neuropathies neurosyphilis meningitis etc The development of neuroAIDS still remains a topic of debate due to multifaceted symptom complicated pathology alon

EDITORIAL SECTION